Full Press Release Details
ADVISORY, Sept. 25, 2007 (PRIME NEWSWIRE) --
John L. Higgins, President and CEO of Ligand Pharmaceuticals
Incorporated (LGND), along with the executive management team and
Board of Directors, will preside over the opening bell.
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
Wednesday, September 26, 2007 at 9:30 a.m. ET
Erika Luib-De la Cruz
858-550-7896; eluib@ligand.com
Jolene Libretto; 646.441.5220; mobile - 347.219.9539
The opening bell is available from 9:20 a.m. to 9:35 a.m. on Galaxy 26, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.
An audio transmission of the opening bell is also available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Waterfront fiber 1623 as well.
A live webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm.
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Ligand Pharmaceuticals Incorporated (LGND):
Ligand discovers and develops new drugs that address critical unmet medical needs of patients in the areas of thrombocytopenia, hepatitis C, cancer, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.